openPR Logo
Press release

Market Access Strategies – Pricing and Reimbursement Landscape in the European Pharmaceutical Market next week in London

10-04-2016 01:05 PM CET | Health & Medicine

Press release from: SMi Group

Market Access Strategies – Pricing and Reimbursement

SMi Group reports: 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference will be returning to London next week.
Payers continue to play an important role in market access. Products are increasingly being rejected for reimbursement, adversely affecting the market share of these products. (Sourse: Medgadget, Sept 2016).

SMi’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference will gather leading industry experts next week in London to discuss the questions such as:
- What strategies can pharmaceutical companies implement in order to overcome the challenges?
- What are the current trends in Health Technology Assessment?
- What are the pricing and reimbursement policies in the US, UK, Turkey, Nordic countries and Japan?

Alexander Natz, Secretary General, EUCOPE will be presenting current challenges in European market access, pricing and reimbursement at the day 1 of the event. Alexander will discuss a better understanding of pricing issues: Euripid Database, EUnetHTA and differential pricing vs international reference pricing.

Simone Breikopf, Head HEOR, Governmental and Public Affairs, Alcon will be focusing on current trends in Health Technology Assessment (HTA): synergy between payers and European HTA bodies, current requirements for harmonisation of HTA and challenges associated with this, early dialogue for medical devices.

Furthermore, an updates from U.S., Turkey, Japan and Nordic countries will be presented. Donald Macarthur, Adviser, Proceutica will present the Turkish story on market access. Updates from the U.S. will be discussed by Ken Walsh, Global Pricing & Market Access Associate, Navigant. Spotlight address: Japan 2016 P&R reforms will be presented by Donald Macarthur, Global Pharmaceutical Business Analys. Rasmus Jensen, Owner; Former Director and Head of Market Access, Drewes Jensen Consult; Lundbeck will be providing a Nordic update – market access outlook.

The event will feature two exclusive post-conference workshops:
A: HTA and reimbursement decisions for innovative medicines. Workshop Leader: Patrick Mollon, Former Director Global Health Economics & Outcomes Research, Novartis; HEOR Director, PMHE2020
B: Managing the global to local challenge (Get all required information for HTA submission) Workshop Leader: Janice Haigh, Practice Leader, Quintiles
The event is only 1 week away - places are filling fast!

For more information please visit: www.pharmaceuticalpricing.co.uk
For media enquiries please contact Anna Serazetdinova on +44 20 7827 6180 or aserazetdinova@smi-online.co.uk
For delegate enquiries contact Fateja Begum +44 (0) 20 7827 6184 or email fbegum@smi-online.co.uk
For sponsorship opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk

---- END ----

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

p: +44 (0) 207 827 6180
e: aserazetdinova@smi-online.co.uk
w: www.smi-online.co.uk
Ground & First Floor
1 Westminster Bridge Road
London, SE1 7XW

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Market Access Strategies – Pricing and Reimbursement Landscape in the European Pharmaceutical Market next week in London here

News-ID: 369037 • Views: 359

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Access

Standalone Access Control Solution
Entry/exit within premises is generally a major challenge of an organization’s overall security strategy. To manage access of specific zones in a single location requires a standalone access control solution. For small and medium business organizations, Matrix has developed COSEC PANEL LITE (site controller), which works independently without requiring a server for Access Control application. All Matrix COSEC biometric and RFID Card based door controllers are connected to the site
Biosimilar Insulin Market Access
Boston, MA ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer
Open Access Journals | International Online Research | Clyto Access
At CLYTO, we believe that peer review is appropriate for evaluating the quality, validity and relevance of scholarly research. We work to establish and maintain peer review integrity through each journal's peer review procedures, to assure the published article is recognized as the final, definitive and citable version of Scholarly Record. Our commitment is evidenced by this declaration of Peer Review Integrity, common to all our journals: All published research articles in
Biosimilar Insulin Market Access
ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer entrants
Ultrafast Access Technologies
FTTH - G.fast - DOCSIS 3.1: what trade-offs between cost, performance and sustainability This report provides a state of the art of the different ultrafast Internet access networks available today: FTTH optical fibre networks; Upgraded cable networks with coax in the last mile, Copper twisted pair networks (phone lines). This state of the art allows for a comparison of the different technologies' technical performance, and to measure the pros and cons of
Access Gateway portfolio rearranged
TELES extends and restructures access gateway portfolio Berlin, Germany – February 7, 2011. TELES, the Berlin-based next generation network and access gateway vendor, today announced its newly arranged and extended portfolio of access gateways. There are three main product lines designating products for carrier and enterprise markets: The VoIPBox product line includes all of the VoIP-ISDN gateways with 4 to 180 VoIP channels and various BRI and PRI interfaces. The ECOTEL